Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 201–250 of 1,926 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05538195	Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors	completed	Phase 1 / Phase 2	17	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Jul 10, 2026	clinicaltrials
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors	recruiting	Phase 2	200	Jazz PharmaceuticalsINDUSTRY	3	Jul 10, 2026	clinicaltrials